Business Description
Shinpoong Pharmaceutical Co Ltd
NAICS : 325412
ISIN : KR7019170000
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.45 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -3.11 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.03 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.4 | |||||
3-Year Book Growth Rate | -10.8 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.7 | |||||
9-Day RSI | 50.93 | |||||
14-Day RSI | 47.85 | |||||
6-1 Month Momentum % | -4.22 | |||||
12-1 Month Momentum % | -4.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 2.1 | |||||
Cash Ratio | 0.93 | |||||
Days Inventory | 148.77 | |||||
Days Sales Outstanding | 123.07 | |||||
Days Payable | 30.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.99 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38.08 | |||||
Operating Margin % | -9.34 | |||||
Net Margin % | -16.71 | |||||
FCF Margin % | -8.22 | |||||
ROE % | -13.06 | |||||
ROA % | -10.24 | |||||
ROIC % | -9.27 | |||||
ROC (Joel Greenblatt) % | -11.64 | |||||
ROCE % | -9.22 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.28 | |||||
PB Ratio | 2.17 | |||||
Price-to-Tangible-Book | 2.22 | |||||
Price-to-Free-Cash-Flow | 182.03 | |||||
Price-to-Operating-Cash-Flow | 38.81 | |||||
EV-to-EBIT | -21.72 | |||||
EV-to-EBITDA | -40.72 | |||||
EV-to-Revenue | 2.6 | |||||
EV-to-FCF | -31.37 | |||||
Price-to-Projected-FCF | 9.38 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Net-Current-Asset-Value | 4.71 | |||||
Earnings Yield (Greenblatt) % | -4.59 | |||||
FCF Yield % | -3.05 | |||||
Forward Rate of Return (Yacktman) % | 3.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shinpoong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 215,439.958 | ||
EPS (TTM) (â‚©) | -710 | ||
Beta | 1.71 | ||
Volatility % | 41.89 | ||
14-Day RSI | 47.85 | ||
14-Day ATR (â‚©) | 417.46697 | ||
20-Day SMA (â‚©) | 11255 | ||
12-1 Month Momentum % | -4.14 | ||
52-Week Range (â‚©) | 10100 - 19850 | ||
Shares Outstanding (Mil) | 51.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shinpoong Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shinpoong Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Shinpoong Pharmaceutical Co Ltd Frequently Asked Questions
What is Shinpoong Pharmaceutical Co Ltd(XKRX:019170)'s stock price today?
When is next earnings date of Shinpoong Pharmaceutical Co Ltd(XKRX:019170)?
Does Shinpoong Pharmaceutical Co Ltd(XKRX:019170) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |